Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

Article Details

Citation

Rettie AE, Wienkers LC, Gonzalez FJ, Trager WF, Korzekwa KR

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

Pharmacogenetics. 1994 Feb;4(1):39-42.

PubMed ID
8004131 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Pharmaco-genomics
DrugInteracting Gene/EnzymeAllele nameGenotypesDefining change(s)Type(s)DescriptionDetails
PhenytoinCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
CelecoxibCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
ClopidogrelCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirements, higher risk for drug-drug interactionsDetails
Acetylsalicylic acidCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
GlipizideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails
TolbutamideCytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
CYP2C9*2Not AvailableEffect InferredPoor drug metabolizer, lower dose requirementsDetails